Anika Therapeutics (ANIK) Intangibles (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Intangibles data on file, last reported at $1.6 million in Q1 2026.

• On a quarterly basis, Intangibles fell 2.94% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 2.94% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, up 175.0% from the prior year.
• Intangibles for Q1 2026 stood at $1.6 million, roughly flat from $1.6 million in the prior quarter.
• Over the last five years, Intangibles for ANIK reached as high as $112.1 million in Q1 2022 and fell as low as $600000.0 in Q4 2024.
• Historically, Intangibles has averaged $49.5 million across 5 years, with a median of $15.7 million in 2025.
• Across the five-year window, Intangibles plunged 97.7% in 2023 and soared 296.47% in 2025, its largest moves.
• Year by year, Intangibles stood at $112.1 million in 2022, then plunged by 97.7% to $2.6 million in 2023, then slumped by 76.71% to $600000.0 in 2024, then surged by 175.0% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $15.7 million in Q3 2025.